Douglas D. Watts

Array ( [id] => 3486451 [patent_doc_number] => 05474903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Process for the quantitative determination of prostate specific antigen' [patent_app_type] => 1 [patent_app_number] => 8/136381 [patent_app_country] => US [patent_app_date] => 1993-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4553 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474903.pdf [firstpage_image] =>[orig_patent_app_number] => 136381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355922 [patent_doc_number] => 06190885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Fusion protein containing HMFG Epitop E (S)' [patent_app_type] => 1 [patent_app_number] => 8/134198 [patent_app_country] => US [patent_app_date] => 1993-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 21126 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190885.pdf [firstpage_image] =>[orig_patent_app_number] => 134198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872815 [patent_doc_number] => 05804187 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Modified antibodies with human milk fat globule specificity' [patent_app_type] => 1 [patent_app_number] => 8/129930 [patent_app_country] => US [patent_app_date] => 1993-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42574 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804187.pdf [firstpage_image] =>[orig_patent_app_number] => 129930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240226 [patent_doc_number] => 06166179 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Inducible endothelial surface protein mediating melanoma cell adhesion, antibodies, and uses' [patent_app_type] => 1 [patent_app_number] => 8/099102 [patent_app_country] => US [patent_app_date] => 1993-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 11186 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166179.pdf [firstpage_image] =>[orig_patent_app_number] => 099102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407575 [patent_doc_number] => 06309880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Antibodies specific for CD4-binding domain of HIV-1' [patent_app_type] => 1 [patent_app_number] => 8/089990 [patent_app_country] => US [patent_app_date] => 1993-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8223 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309880.pdf [firstpage_image] =>[orig_patent_app_number] => 089990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2994646 [patent_doc_number] => 05358788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Organic electroluminescence device containing a silanamine compound' [patent_app_type] => 1 [patent_app_number] => 8/035676 [patent_app_country] => US [patent_app_date] => 1993-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12021 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358788.pdf [firstpage_image] =>[orig_patent_app_number] => 035676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459082 [patent_doc_number] => 06391634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Monoclonal antibodies and their production and use' [patent_app_type] => B1 [patent_app_number] => 08/031075 [patent_app_country] => US [patent_app_date] => 1993-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2858 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391634.pdf [firstpage_image] =>[orig_patent_app_number] => 08031075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340436 [patent_doc_number] => 06586209 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Xylanase production' [patent_app_type] => B1 [patent_app_number] => 07/955726 [patent_app_country] => US [patent_app_date] => 1993-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 19164 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586209.pdf [firstpage_image] =>[orig_patent_app_number] => 07955726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3980050 [patent_doc_number] => 05861156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Methods of delivering agents to target cells' [patent_app_type] => 1 [patent_app_number] => 8/002324 [patent_app_country] => US [patent_app_date] => 1993-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 11450 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861156.pdf [firstpage_image] =>[orig_patent_app_number] => 002324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363002 [patent_doc_number] => 06569834 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Elucidation and synthesis of antineoplastic tetrapeptide w-aminoalkyl-amides' [patent_app_type] => B1 [patent_app_number] => 07/985697 [patent_app_country] => US [patent_app_date] => 1992-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4134 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569834.pdf [firstpage_image] =>[orig_patent_app_number] => 07985697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3861319 [patent_doc_number] => 05792852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Polynucleotides encoding modified antibodies with human milk fat globule specificity' [patent_app_type] => 1 [patent_app_number] => 7/977696 [patent_app_country] => US [patent_app_date] => 1992-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36908 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 629 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792852.pdf [firstpage_image] =>[orig_patent_app_number] => 977696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409501 [patent_doc_number] => 06310040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs' [patent_app_type] => 1 [patent_app_number] => 7/963329 [patent_app_country] => US [patent_app_date] => 1992-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 6326 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310040.pdf [firstpage_image] =>[orig_patent_app_number] => 963329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3053356 [patent_doc_number] => 05356782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-18 [patent_title] => 'Analytical test apparatus with on board negative and positive control' [patent_app_type] => 1 [patent_app_number] => 7/940059 [patent_app_country] => US [patent_app_date] => 1992-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 15460 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/356/05356782.pdf [firstpage_image] =>[orig_patent_app_number] => 940059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247984 [patent_doc_number] => 06673559 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Met proto-oncogene and a method for predicting breast cancer progression' [patent_app_type] => B1 [patent_app_number] => 07/903588 [patent_app_country] => US [patent_app_date] => 1992-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 5710 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673559.pdf [firstpage_image] =>[orig_patent_app_number] => 07903588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1554192 [patent_doc_number] => 06348570 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Chromophore containing compounds and their use in determining interleukin-1 convertase activity' [patent_app_type] => B1 [patent_app_number] => 07/808994 [patent_app_country] => US [patent_app_date] => 1991-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9654 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348570.pdf [firstpage_image] =>[orig_patent_app_number] => 07808994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3455529 [patent_doc_number] => 05401638 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Detection and quantification of neu related proteins in the biological fluids of humans' [patent_app_type] => 1 [patent_app_number] => 7/806112 [patent_app_country] => US [patent_app_date] => 1991-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 12718 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401638.pdf [firstpage_image] =>[orig_patent_app_number] => 806112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579327 [patent_doc_number] => 06448381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'DNA encoding heparin-binding growth factor' [patent_app_type] => B1 [patent_app_number] => 07/542232 [patent_app_country] => US [patent_app_date] => 1990-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4374 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448381.pdf [firstpage_image] =>[orig_patent_app_number] => 07542232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2767080 [patent_doc_number] => 05006567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-09 [patent_title] => 'Process for foaming polymer compositions with hydrazone compounds and compositions associated therewith' [patent_app_type] => 1 [patent_app_number] => 7/255572 [patent_app_country] => US [patent_app_date] => 1988-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4851 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/006/05006567.pdf [firstpage_image] =>[orig_patent_app_number] => 255572 [rel_patent_id] =>[rel_patent_doc_number] =>)